The Effectiveness and Safety of Niacinamide 4% and Virgin Coconut Oil 30% for Secondary Prevention of Occupational Hand Dermatitis
Comparison of the Effectiveness and Safety Between Moisturizing Cream Containing Niacinamide 4% and Virgin Coconut Oil 30% for Secondary Prevention of Occupational Hand Hermatitis in Intensive Care Unit Nurses: a Double Blind Randomized Clinical Trial
Sponsors |
Lead Sponsor: Indonesia University |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Source | Indonesia University | ||||||||||||||
Brief Summary | Occupational hand dermatitis (OHD) often occurs in intensive care unit (ICU) nurses, especially in individuals who are vulnerable due to irritant exposure e.g. hand rub alcohol and repeated hand washing activities. The use of moisturizer is one of the recommendations for skin care in OHD. Niacinamide which has anti-inflammatory effects and can improve the skin barrier function. Virgin coconut oil (VCO) is rich in lipids and lauric acid, and has an occlusive effect. Until now there are no guidelines and reference types of moisturizers for secondary prevention in DTAK. |
||||||||||||||
Detailed Description | The aim of this study is identify the effectiveness and safety between moisturizing cream containing niacinamide 4% and VCO 30% for secondary prevention of occupational hand dermatitis in ICU nurses This study also measured HECSI , TEWL, and SCap before and after treatment |
||||||||||||||
Overall Status | Completed | ||||||||||||||
Start Date | September 3, 2019 | ||||||||||||||
Completion Date | December 31, 2019 | ||||||||||||||
Primary Completion Date | October 15, 2019 | ||||||||||||||
Phase | N/A | ||||||||||||||
Study Type | Interventional | ||||||||||||||
Primary Outcome |
|
||||||||||||||
Enrollment | 92 | ||||||||||||||
Condition | |||||||||||||||
Intervention |
Intervention Type: Other Intervention Name: Niacinamide 4% Description: cream moisturizer Arm Group Label: Niacinamide 4% Intervention Type: Other Intervention Name: Virgin Coconut oil 30% Description: cream moisturizer Arm Group Label: Virgin coconut oil 30% |
||||||||||||||
Eligibility |
Criteria:
Inclusion Criteria: ICU nurses who: - Sign the informed consent of the study after receiving explanation before all activity related with this study begin. - Has Occupation Hand Dermatitis that fulfill the Mathias criteria with dermatitis severity mild to moderate which the score is 1, 2 or 3 corresponding with Investigator Global Assesment (IGA) - Agree to follow the study protocol Exclusion Criteria: - History of allergic or irritate by Niacinamide or VCO or other component in moisturizer - Receiving medium to high potency of topical Corticosteroid or systemic immunosupresant therapy or history of oral corticosteroid therapy in the last 1 month Gender: All Minimum Age: 18 Years Maximum Age: 58 Years Healthy Volunteers: No |
||||||||||||||
Overall Official |
|
||||||||||||||
Location |
|
||||||||||||||
Location Countries |
Indonesia |
||||||||||||||
Verification Date |
September 2019 |
||||||||||||||
Responsible Party |
Type: Principal Investigator Investigator Affiliation: Indonesia University Investigator Full Name: Yenny Rachmawati Investigator Title: Principal investigator |
||||||||||||||
Keywords | |||||||||||||||
Has Expanded Access | No | ||||||||||||||
Condition Browse | |||||||||||||||
Number Of Arms | 2 | ||||||||||||||
Arm Group |
Label: Niacinamide 4% Type: Active Comparator Description: Niacinamide 4%, applied twice daily for 28 days Label: Virgin coconut oil 30% Type: Active Comparator Description: Virgin coconut oil 30%, applied twice daily for 28 days |
||||||||||||||
Patient Data | No | ||||||||||||||
Study Design Info |
Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: There were 46 subjects in the niacinamide 4% arm and 46 subjects in the VCO 30% arm Primary Purpose: Prevention Masking: Double (Participant, Investigator) Masking Description: Both moisturizers have the same physical characteristics, with the same color and odor. Randomization was carried out by other than researcher (statistical adviser) |
Clinical Research News
- Apr 16
- Apr 14
- Apr 14
- Apr 14
- Apr 14
- Apr 14
- Apr 14
- Apr 14
- Apr 13
- Apr 13